MARTINELLI, ADRIANO
 Distribuzione geografica
Continente #
NA - Nord America 13.982
EU - Europa 5.858
AS - Asia 2.790
AF - Africa 118
SA - Sud America 21
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.784
Nazione #
US - Stati Uniti d'America 13.605
IT - Italia 2.075
CN - Cina 1.545
SE - Svezia 1.135
DE - Germania 731
BG - Bulgaria 589
TR - Turchia 394
CA - Canada 376
SG - Singapore 359
UA - Ucraina 293
GB - Regno Unito 291
VN - Vietnam 273
FI - Finlandia 234
FR - Francia 137
CH - Svizzera 111
IN - India 93
RU - Federazione Russa 68
AT - Austria 58
BE - Belgio 56
HK - Hong Kong 55
CI - Costa d'Avorio 45
SN - Senegal 38
JP - Giappone 19
GR - Grecia 18
NG - Nigeria 16
BR - Brasile 13
IR - Iran 13
PL - Polonia 12
KR - Corea 10
PK - Pakistan 10
AU - Australia 9
ES - Italia 9
ID - Indonesia 7
RO - Romania 7
MA - Marocco 6
BJ - Benin 5
IE - Irlanda 5
NL - Olanda 5
DK - Danimarca 4
CL - Cile 3
CO - Colombia 3
DZ - Algeria 3
EU - Europa 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TW - Taiwan 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HU - Ungheria 2
LI - Liechtenstein 2
SI - Slovenia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AM - Armenia 1
AR - Argentina 1
BN - Brunei Darussalam 1
CY - Cipro 1
EG - Egitto 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MX - Messico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
Totale 22.784
Città #
Woodbridge 2.269
Ann Arbor 2.075
Houston 1.395
Fairfield 1.257
Chandler 1.008
Ashburn 691
Serra 633
Milan 590
Sofia 588
Seattle 525
Chengdu 509
Wilmington 434
Beijing 416
Jacksonville 392
Izmir 379
Cambridge 372
Ottawa 353
New York 323
Boardman 248
Princeton 240
Lawrence 217
Singapore 209
Nanjing 202
Medford 180
Dong Ket 163
Des Moines 142
Dearborn 118
Marseille 106
Bern 103
Nanchang 86
Florence 77
Boulder 66
Jüchen 65
San Diego 65
Redwood City 59
Hong Kong 53
Los Angeles 53
London 49
Vienna 49
Abidjan 45
Brussels 43
Rome 43
Kunming 40
Dakar 38
Nürnberg 37
Shenyang 35
Kansas City 34
Ogden 33
Chicago 31
Jiaxing 31
Hebei 29
Tianjin 29
Pune 28
Changsha 27
Detroit 26
Norwalk 26
Falls Church 25
Bremen 23
Frankfurt am Main 23
Hefei 20
Hangzhou 19
Washington 18
Auburn Hills 16
Guangzhou 16
Indiana 16
Lagos 16
Orange 16
Pisa 16
Grafing 15
San Francisco 15
Dallas 14
Lanzhou 14
Düsseldorf 13
Rho 13
Toronto 12
Warsaw 12
Phoenix 11
Louvain-la-Neuve 9
Santa Clara 9
Frisco 8
Jinan 8
Lancaster 8
Leawood 8
Pieve Fosciana 8
Pistoia 8
Alessandria 7
Shanghai 7
São Paulo 7
Tokyo 7
Costa Mesa 6
Council Bluffs 6
Genova 6
Livorno 6
Ningbo 6
Paris 6
Rosignano Marittimo 6
Augusta 5
Bologna 5
Cotonou 5
Helsinki 5
Totale 17.833
Nome #
null 595
1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations 237
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 232
Synthesis and 3D QSAR of New Pyrazolo[3,4-b]pyridines: Potent and Selective Inhibitors of A1 Adenosine Receptors 202
Receptor-based virtual screening evaluation for the identification of estrogen receptor β ligands 184
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. 184
Synthesis and biological evaluation of non-glucose glycoconjugated N-hydroyxindole class LDH inhibitors as anticancer agents 183
Phenylpropanoids and flavonoids from Phlomis kurdica as inhibitors of human lactate dehydrogenase. 176
Identification of Lactate Dehydrogenase 5 Inhibitors using Pharmacophore- Driven Consensus Docking 168
THERMODYNAMIC PROPERTIES OF ORGANIC COMPOUNDS IN AQUEOUS-SOLUTIONS - APPARENT MOLAL HEAT-CAPACITIES OF AMINES AND ETHERS 161
Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors 161
Chimica - VI Edizione Copyright © 2017, EdiSES srl - Napoli 161
1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations 157
1,2-disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors 150
Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes 150
Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model 149
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 144
The [(Methyloxy)imino]methyl Moiety as a Bioisoster of Aryl. A Novel Class of Completely Aliphatic Beta-Adrenergic Receptor Antagonists 144
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 143
X-Ray analysis, theoretical studies and alfa-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue. 143
Design, Synthesis and biological evaluation of new 1,8-naphthyridin-4(1h)-on-3-carboxamide and quinolin-4(1h)-on-3-carboxamide derivatives as CB2 selective agonists 141
D3 dopamine receptor subtype: which binding modes for such different ligands?, 140
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 140
CONFORMATIONAL STUDY OF ALPHA-BLOCKING ADRENERGIC-DRUGS WITH BENZODIOXANE STRUCTURE 138
Computational studies of EGFR inhibitors: Docking, 3D-QSAR analysis and virtual screening evaluation 138
Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform a (LDH-A) as Starvation Agents against Cancer Cells 138
Conformationally restrained β -blocking oxime ethers: synthesis and β -adrenergic properties of diastereoisomeric anti and syn 2-(5-isoxazolidinyl)ethanolamines 137
Rational design, synthesis, biological evaluation and labelling of selective cannabinoid CB2 receptor agonists as anticancer agents 136
Dual Targeting of the Warburg Effect with a Glucose-Conjugated Lactate Dehydrogenase Inhibitor 136
An overview of recent developments in GPCR modelling: methods and validation 134
COMPOUNDS INHIBITING THE ENZYME LACTATE DEHYDROGENASE (LDH), PHARMACEUTICAL COMPOSITIONS AND USES THEREOF 133
N-ALKYL-NOR-TROPINE ESTERS OF 2-PHENYL-CYCLOHEXENIC ACIDS AS NEW BRONCHODILATOR AGENTS - EFFECT OF STRUCTURAL AND CONFORMATIONAL MODIFICATIONS ON AFFINITY FOR MUSCARINIC RECEPTORS 132
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 131
Selective activators of estrogen receptor beta based on the aldoxime and ketoxime scaffolds 130
MOLECULAR-ORBITAL STUDIES ON MECHANISM OF DRUG-RECEPTOR INTERACTION .2. BETA-ADRENERGIC DRUGS - APPROACH TO EXPLAIN ROLE OF AROMATIC MOIETY 129
Role of the acyloxymethyl moiety in eliciting the adrenergic ß-blocking activity of 3-acyloxypropanolamines 129
Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5 129
Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds 127
A Virtual Screening Study for Lactate Dehydrogenase 5 Inhibitors by using a Pharmacophore-Based Approach 127
Cannabinoid CB2/CB1 Selectivity. Receptor Modeling and Automated Docking Analysis 126
Antiproliferative oxime derivatives that inhibit glucose transporter 1 (GLUT1) in cancer cells 126
Identification of new FYN kinase inhibitors using a FLAP-based approach 126
Synthesis and ß-adrenergic properties of (E)-N-[3-(alkylamino)-2- hydroxypropilidene](methyloxy)amines substituted with an aromatic group on their [(methyloxy)imino]methyl moiety (MOIMM): an investigation into the biopharmacological effects of an aryl substitution in the class of MOIM ß-blocking drugs. 125
Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides 125
Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies 125
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors 124
SYNTHESIS, ANTIINFLAMMATORY ACTIVITY AND MOLECULAR-ORBITAL STUDIES OF A SERIES OF BENZYLIDENEAMINOXYPROPIONIC ACIDS SUBSTITUTED ON THE PHENYL RING 124
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition 124
X-ray analisis, theoretical studies and a-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue 122
Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors 122
Conformationally restrained analogues of sympathomimetic catecholamines: Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2′,5′- morpholines] 121
Conformationally Restrained Analogs of Sympathomimetic Catecholamines. Synthesis, Conformational Analysis, and Adrenergic Activity of Isochroman Derivatives 120
CONFORMATIONALLY RESTRAINED ANALOGS OF SYMPATHOMIMETIC CATECHOLAMINES - SYNTHESIS AND ADRENERGIC ACTIVITY OF TETRAHYDROBENZOCYCLOHEPTENE DERIVATIVES 119
Conformationally restrained ß-blocking oxime ethers. 2. Synthesis and ß-adrenergic properties of diastereoisomeric anti and syn 2-(5’-(3’-aryl-substituted)isoxazolidinyl)-N-alkylethanolamines 118
Computational Studies on Translocator Protein (TSPO) and its Ligands 118
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells 118
Conformational effects on the activity of drugs. 13. A revision of previously proposed models for the activation of alfa- and beta-adrenergic receptors 117
D3 dopamine receptor subtype: which binding modes for such different ligands? 117
null 117
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 117
N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis 116
N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation 116
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds 116
Olivetol- and Resorcinol-Anandamide “hybrids”: design, synthesis, binding and molecular modeling of potent cannabinoid receptor ligands 115
An interdisciplinary approach to the design of new structures active at the beta-adrenergic receptor. Aliphatic oxime ether derivatives 115
Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models 115
Structure-Activity Relationship Studies of a New Series of Imidazo2,1-fpurinones as Potent and Selective A3 Adenosine Receptor Antagonists 115
A CONFORMATIONAL APPROACH TO HISTAMINE H-2-RECEPTOR ANTAGONISTS 114
Novel aminopteroil-sulfonamide derivatives as inhibitors of dihydrofolate reductase and carbonic anhydrase, with potential anti tumor activity 114
Design of transthyretin amyloidosis inhibitors: A docking and virtual screening approach 114
Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor 114
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 114
Synthesis and antimicrobial properties of substituted 3-aminoxy-(E)-2-methoxyiminopropionyl penicillins and cephalosporins 113
2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity 113
Dual Inhibitors of Matrix Metalloproteinases and Carbonic Anhydrases: Iminodiacetyl-Based Hydroxamate-Benzenesulfonamide Conjugates 113
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors 113
Multitemplate Alignment Method for the Development of a Reliable 3D-QSAR Model for the Analysis of MMP3 Inhibitors 113
MOLECULAR DESIGN, SYNTHESIS, AND ANTIINFLAMMATORY ACTIVITY OF A SERIES OF BETA-AMINOXYPROPIONIC ACIDS 111
Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach 111
Analysis of Human Carbonic Anhydrase II: Docking Reliability and Receptor-Based 3D-QSAR Study 110
Triazole-substituted N-hydroxyindol-2-carboxylates as inhibitors of isoform 5 of human lactate dehydrogenase (hLDH5) 110
Different Binding Modes of Structurally Diverse Ligands for Human D3DAR 110
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors 109
Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors 108
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 108
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with Antinociceptive Activity in Vivo 108
Design, synthesis, and biological evaluation of 1,8-naphthyridin-2(1H)-on-3-carboxamide, quinolin-2(1H)-on-3-carboxamide and 2-oxo-1,2-dihydropyridine-3-carboxamide derivatives as CB2 selective ligands 107
QSAR of Carbonic Anhydrase Inhibitors and Their Impact on Drug Design 107
3D-QSAR and virtual screening studies for the translocator protein(TSPO) 107
Structural optimization of 4-chlorobenzoylpiperidine derivatives for the development of potent, reversible and selective monoacylglycerol lipase (MAGL) inhibitors 107
Indoles and Related Compounds as Cannabinoid Ligands, 106
Computational Studies of Epidermal Growth Factor Receptor for Docking Reliability, Three-Dimensional Quantitative Structure-Activity Relationship Analysis, and Virtual Screening Studies 106
1-benzilossiimmino-3- ammino-2-propanoli: sintesi e proprietà ß-adrenergiche 105
Synthesis, Antifungal Activity, and Molecular Modeling Studies of New Inverted Oxime Ethers of Oxiconazole 105
Unusual nitration of substituted 7-amino-1,8-naphthyridine in the synthesis of compounds with antiplatelet activity 105
ROLE OF THE (ACYLOXY)METHYL MOIETY IN ELICITING THE ADRENERGIC BETA-BLOCKING ACTIVITY OF 3-(ACYLOXY)PROPANOLAMINES 105
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 105
Substituted Pyrazolo3,4-bpyridines as Potent A1 Adenosine Antagonists: Synthesis, Biological Evaluation, and Development of an A1 Bovine Receptor Model 105
Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies 105
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 105
Totale 13.328
Categoria #
all - tutte 56.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.549 0 0 0 221 329 404 422 247 317 246 274 89
2020/20211.875 174 188 115 72 205 82 100 197 154 138 112 338
2021/20222.630 59 197 74 185 450 344 78 145 84 75 167 772
2022/20232.902 374 368 191 275 312 430 28 197 494 21 167 45
2023/20242.193 358 262 267 152 333 386 87 43 41 32 39 193
2024/2025456 38 252 113 53 0 0 0 0 0 0 0 0
Totale 23.063